Rethinking how to stop antidepressants: withdrawal risks reshape treatment
New research indicates that withdrawal symptoms from SSRIs are more common and severe than previously acknowledged, prompting medical bodies to revise guidelines for tapering off the drugs. A psychiatrist who experienced severe withdrawal himself is among those advocating for a more cautious approach. The growing evidence is leading to changes in how depression is treated.
The article highlights a significant shift in medical understanding of SSRI antidepressants, which are taken by roughly one in six Americans and similar proportions in the UK and Australia. While these drugs were initially favored over older tricyclic antidepressants due to fewer dangerous side effects, long-term use has revealed a different problem: withdrawal can be severe and prolonged. Research fellow Mark Horowitz's personal experience of panic attacks and dissociation after tapering escitalopram mirrors findings from recent studies suggesting withdrawal symptoms are more common than previously documented.
Clinical guidelines have historically offered little direction on how or when to revisit antidepressant prescriptions, leaving many patients to manage discontinuation without adequate support. Survey data indicates most users still find the drugs helpful, and a 2024 analysis of over 670,000 people confirmed modest effectiveness. However, the growing recognition of withdrawal challenges is prompting medical bodies to reconsider both prescribing practices and tapering protocols.
This shift in understanding could affect millions of long-term antidepressant users who may face difficult discontinuation experiences without adequate medical guidance. Patients may become more cautious about starting these medications, while doctors could adjust prescribing practices and develop structured tapering protocols. The debate may also influence public perception of depression treatment, potentially leading to more personalized approaches that weigh long-term risks against benefits. Healthcare systems could face increased demand for specialized withdrawal support services.